Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2003 Sep 28;324(8403):617–621. doi: 10.1016/S0140-6736(84)90604-4

ANTIVIRAL THERAPY

Respiratory Infections, Genital Herpes, and Herpetic Keratitis

KG Nicholson 1
PMCID: PMC7141569  PMID: 6147649

The content is available as a PDF (810.2 KB).

References

REFERENCES

  • Quilligan Jj, Hirayama M., Baernstein HD. The suppression of A2 influenza in children by the chemoprophylactic use of amantadine. J Pediatr. 1966;69:572–575. doi: 10.1016/s0022-3476(66)80042-2. [DOI] [PubMed] [Google Scholar]
  • 2.O'Donoghue Jm, Ray Cg, Terry Dw. Prevention of nosocomial influenza infection with amantadine. Am J Epidemiol. 1973;97:276–282. doi: 10.1093/oxfordjournals.aje.a121509. [DOI] [PubMed] [Google Scholar]
  • 3.Payler Dk, Purdham Pa. Influenza A prophylaxis with amantadine in a boarding school. Lancet. 1984;i:502–504. doi: 10.1016/s0140-6736(84)92861-7. [DOI] [PubMed] [Google Scholar]
  • 4.Zlydnikow Dm, Kubar Oi, Kovaleva Tp. Study of rimantadine in the U.S S R a review of the literature. Rev Inf Dis. 1981;3:408–421. doi: 10.1093/clinids/3.3.408. [DOI] [PubMed] [Google Scholar]
  • 5.Oxford Js, Galbraith A. Antiviral activity of amantadine; a review of laboratory and clínical data. Pharmacol Ther. 1980;11:181–262. doi: 10.1016/0163-7258(80)90072-8. [DOI] [PubMed] [Google Scholar]
  • 6.Dolin R., Reichman Rc, Madore Hp. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982;307:580–584. doi: 10.1056/NEJM198209023071002. [DOI] [PubMed] [Google Scholar]
  • 7.Solov'ev VD. The results of controlled observations on the prophylaxis of influenza with interferon. Bull WHO. 1969;41:683–688. [PMC free article] [PubMed] [Google Scholar]
  • 8.Wingfield Wl, Pollack D., Grunert RR. Therapeutic efficacy of amantadine HCl and rimantadine HCI in naturally occurring influenza A2 respiratory illness in man. N Engl J Med. 1969;281:579–584. doi: 10.1056/NEJM196909112811102. [DOI] [PubMed] [Google Scholar]
  • 9.Van Voris Lp, Betts Rf, Hayden Fg. Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA. 1981;245:1128–1131. doi: 10.1001/jama.245.11.1128. [DOI] [PubMed] [Google Scholar]
  • 10.Little Jw, Hall Wh, Douglas Rg. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Resp Dis. 1978;118:295–303. doi: 10.1164/arrd.1978.118.2.295. [DOI] [PubMed] [Google Scholar]
  • 11.Hayden Fg, Hall Wj, Douglas Rg. Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus. J Inf Dis. 1980;141:535–542. doi: 10.1093/infdis/141.5.535. [DOI] [PubMed] [Google Scholar]
  • 12.Hayden Fg, Zlydnikov Dm, Iljenko Vi. Comparative therapeutic effect of aerosolized and oral rimantadine HCl in experimental human influenza A virus infection. Antiviral Res. 1982;2:147–153. doi: 10.1016/0166-3542(82)90016-x. [DOI] [PubMed] [Google Scholar]
  • 13.Knight V., McClung Hw, Wilson Sz. Ribavirin small-particle aerosol treatment of influenza. Lancet. 1981;ii:945–949. doi: 10.1016/s0140-6736(81)91152-1. [DOI] [PubMed] [Google Scholar]
  • 14.McClung Hw, Knight V., Gilbert Be. Ribavirin aerosol treatment ofinfluenza B virus infection. JAMA. 1983;249:2671–2674. [PubMed] [Google Scholar]
  • 15.Hall Cb, Walsh Ee, Hruska Jf. Ribavirin treatment of experimental respiratory syncytial viral infection. JAMA. 1983;249:2666–2670. [PubMed] [Google Scholar]
  • 16.Hall Cb, McBride Jt, Walsh Ee. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med. 1983;308:1443–1447. doi: 10.1056/NEJM198306163082403. [DOI] [PubMed] [Google Scholar]
  • 17.Taber Lh, Knight V., Gilbert Be. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics. 1983;72:613–618. [PubMed] [Google Scholar]
  • 18.Merigan Tc, Reed Se, Hall Ts. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973;i:563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  • 19.Herzog C., Just M., Berger R. Intranasal interferon for contact prophylaxis against common cold in families. Lancet. 1983;ii:962. doi: 10.1016/s0140-6736(83)90470-1. [DOI] [PubMed] [Google Scholar]
  • 20.Scott Gm, Reed S., Cartwright T. Failure of human fibroblast interferon to protect against rhinovirus infection. Arch Virol. 1980;65:135–139. doi: 10.1007/BF01317324. [DOI] [PubMed] [Google Scholar]
  • 21.Hill Da, Baron S., Perkins Jc. Evaluation of an interferon inducer in viral respiratory disease. JAMA. 1972;219:1179–1184. [PubMed] [Google Scholar]
  • 22.Betts Rf, Douglas RG. Interferon inducers: propanediamines and related molecules. In: Stringfellow D., editor. Marcel Dekker; New York: 1980. pp. 223–237. (Interferon and interferon inducers: clinical applications.). [Google Scholar]
  • 23.Gelfand Ew, McCurdy D., Rao Cp. Ribavirin treatment of viral pneumonitis in severe combined immunodeficiency disease. Lancet. 1983;ii:732–733. doi: 10.1016/s0140-6736(83)92265-1. [DOI] [PubMed] [Google Scholar]
  • 24.Higgins Pg, Phillpotts Rj, Scott Gm. Intranasal interferon as protection against experimental coronavirus infection in volunteers. Antimicrob Ag Chemother. 1983;24:713–715. doi: 10.1128/aac.24.5.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fiddian Ap, Kinghorn Gr, Goldmeier D. Topical acyclovir in the treatment of genital herpes. a comparison with systemic therapy. J Antimicrob Chemother. 1983;12(suppl B):67–77. doi: 10.1093/jac/12.suppl_b.67. [DOI] [PubMed] [Google Scholar]
  • 26.Corey L., Nahmias Aj, Guinan Me. A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med. 1982;306:1313–1319. doi: 10.1056/NEJM198206033062201. [DOI] [PubMed] [Google Scholar]
  • 27.Corey L., Benedetti Jk, Critchlow Cw. Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. Am J Med. 1982;73 1A:326–334. doi: 10.1016/0002-9343(82)90117-6. [DOI] [PubMed] [Google Scholar]
  • 28.Bryson Yj, Dillon M., Lovett M. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. N Engl J Med. 1983;308:916–921. doi: 10.1056/NEJM198304213081602. [DOI] [PubMed] [Google Scholar]
  • 29.Fiddian Ap, Halsos Am, Kinge Rb. Oral acyclovir in the treatment of genital herpes. Am J Med. 1982;73 1A:335–337. doi: 10.1016/0002-9343(82)90118-8. [DOI] [PubMed] [Google Scholar]
  • 30.Nilsen Ae, Aasen T., Halsos Am. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet. 1982;ii:571–573. doi: 10.1016/s0140-6736(82)90658-4. [DOI] [PubMed] [Google Scholar]
  • 31.Mindel A., Adler Mw, Sutherland S. Intravenous acyclovir treatment for primary genital herpes. Lancet. 1982;i:697–700. doi: 10.1016/s0140-6736(82)92618-6. [DOI] [PubMed] [Google Scholar]
  • 32.Corey L., Fife Kh, Benedetti J. Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med. 1983;98:914–921. doi: 10.7326/0003-4819-98-6-914. [DOI] [PubMed] [Google Scholar]
  • 33.Reichman Rc, Badger Gj, Guinan Me. Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Inf Dis. 1983;147:336–340. doi: 10.1093/infdis/147.2.336. [DOI] [PubMed] [Google Scholar]
  • 34.Reichman Rc, Ginsberg M., Barrett-Connor E. Controlled trial of oral acyclovir in the therapy of recurrent herpes simplex genitalis. Am J Med. 1982;731A:338–341. doi: 10.1016/0002-9343(82)90119-x. [DOI] [PubMed] [Google Scholar]
  • 35.Reichman Rc, Badger Gj, Mertz Gj. Treatment of recurrent genital herpes simplex infections with oral acyclovir. JAMA. 1984;251:2103–2107. [PubMed] [Google Scholar]
  • 36.Straus Se, Takiff He, Seidlin M. Suppression of frequently recurring genital herpes a placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984;310:1545–1550. doi: 10.1056/NEJM198406143102401. [DOI] [PubMed] [Google Scholar]
  • 37.Douglas Jm, Critchlow C., Benedetti J. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med. 1984;310:1551–1556. doi: 10.1056/NEJM198406143102402. [DOI] [PubMed] [Google Scholar]
  • 38.Mindel A., Weller Ivd, Faherty A. Prophylactic oral acyclovir in recurrent genital herpes. Lancet. 1984;ii:57–59. doi: 10.1016/s0140-6736(84)90237-x. [DOI] [PubMed] [Google Scholar]
  • 39.Taylor Pk, Doherty NR. Comparison of the treatment of herpes genitalis in men with proflavine photoinactivation, idoxuridine ointment, and normal saline. Br J Vener Dis. 1975;51:125–129. doi: 10.1136/sti.51.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Parker JD. A double-blind trial of idoxuridine in recurrent genital herpes. J Antimicrob Chemother. 1977;3(suppl A):131–137. doi: 10.1093/jac/3.suppl_a.131. [DOI] [PubMed] [Google Scholar]
  • 41.Silvestri Dl, Corey L., Holmes KK. Ineffectiveness of topical idoxuridine in dimethylsulphoxide for therapy for genital herpes. JAMA. 1982;248:953–959. [PubMed] [Google Scholar]
  • 42.Bierman Sm, Kirkpatrick W., Fernandez H. Clinical efficacy of ribavirin in the treatment of genital herpes simplex virus infection. Chemotherapy. 1981;27:139–145. doi: 10.1159/000237969. [DOI] [PubMed] [Google Scholar]
  • 43.Blough Ha, Giuntoli RL. Successful treatment of human genital herpes infections with 2-deoxy-D-glucose. JAMA. 1979;241:2798–2801. [PubMed] [Google Scholar]
  • 44.Carroll Jm, Martola E-L., Laibson Pr. The recurrence of herpetic keratitis following idoxuridine therapy. Am J Ophthalmol. 1967;63:103–107. doi: 10.1016/0002-9394(67)90583-1. [DOI] [PubMed] [Google Scholar]
  • 45.Collum Lmt, Benedict-Smith A., Hillary IB. Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration. Br J Ophthalmol. 1980;64:766–769. doi: 10.1136/bjo.64.10.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Gold Ja, Stewart Rc, McKee J. The epidemiology and chemotherapy of herpes simplex keratitis and herpes simplex skin infections. Ann N Y Acad Sci. 1965;130:209–212. doi: 10.1111/j.1749-6632.1965.tb12553.x. [DOI] [PubMed] [Google Scholar]
  • 47.Pavan-Langston D., Buchanan RA. Vidarabine therapy of simple and IDU-complicated herpetic keratitis. Trans Am Acad Ophthalmol Otol. 1976;81:OP813–25. [PubMed] [Google Scholar]
  • 48.Jones DB. Adenine arabinoside in herpes simplex karatitis, treatment of idoxuridine-failure epithelial disease, and combined corticosteroid therapy in stromal keratitis. In: Pavan-Langston D., Buchanan Ra, Alford Ca, editors. Raven Press; New York: 1975. pp. 371–379. (Adenine arabinoside: an antiviral agent.). [Google Scholar]
  • 49.Pavan-Langston D., Dohlman Ch, Geary P. Intraocular penetration of adenine arabinoside and idoxuridine—therapeutic implications in clinical herpetic uveitis. In: Pavan-Langston D., Buchanan Ra, Alford Ca, editors. Raven Press; New York: 1975. pp. 293–312. (Adenine arabinoside. an antiviral agent.). [Google Scholar]
  • 50.Heidelberger C., King DH. Trifluorothymidine. Pharmacol Ther. 1979;6:427–442. [Google Scholar]
  • 51.Wellings Pc, Awdry Pn, Bors Fh. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol. 1977;73:932–942. doi: 10.1016/0002-9394(72)90463-1. [DOI] [PubMed] [Google Scholar]
  • 52.Coster Dj, McKinnon Jr, McGill Ji. Clinical evaluation of adenine arabinoside and trifluorothymidine m the treatment of corneal ulcers caused by herpes simplex virus. J Inf Dis. 1976;133(suppl: A):173–177. doi: 10.1093/infdis/133.supplement_2.a173. [DOI] [PubMed] [Google Scholar]
  • 53.Coster Dj, Jones Br, McGill JI. Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine. Br J Ophthalmol. 1979;63:418–421. doi: 10.1136/bjo.63.6.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.McKinnon Jr, McGill Ji, Jones BR. A coded clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of ulcerative herpetic keratitis. In: Pavan-Langston D., Buchanan Ra, Alford Ca, editors. Raven Press; New York: 1975. pp. 401–410. (Adenine arabmoside: an antiviral agent.). [Google Scholar]
  • 55.Coster Dj, Wilhelmus Kr, Michaud R. A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis. Br J Ophthalmol. 1980;64:763–765. doi: 10.1136/bjo.64.10.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.McGill J., Tormey P., Walker Cb. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br J Ophthalmol. 1981;65:610–613. doi: 10.1136/bjo.65.9.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Pavan-Langston D., Lass J., Hettinger M. Acyclovir and vidarabine in the treatment of ulcerative herpes simplex keratitis. Am J Ophthalmol. 1981;92:829—35. doi: 10.1016/s0002-9394(14)75638-7. [DOI] [PubMed] [Google Scholar]
  • 58.La Lau C., Oosterhuis Ja, Versteeg J. Multicenter trial of acyclovir and trifluorothymidine in herpetic keratitis. Am J Med. 1982;73(1A):305–306. doi: 10.1016/0002-9343(82)90111-5. [DOI] [PubMed] [Google Scholar]
  • 59.Maugdal Pc, Missoten L., De Clercq E. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine m the topical treatment of herpes simplex keratitis. Albrecht von Graefes Arch Klin Ophthalmol. 1981;216:261–268. doi: 10.1007/BF00455033. [DOI] [PubMed] [Google Scholar]
  • 60.Dunnick Jk, Galasso GJ. Update on clinical trials with exogenous interferon. J Inf Dis. 1980;142:293–299. doi: 10.1093/infdis/142.2.293. [DOI] [PubMed] [Google Scholar]
  • 61.Sundmacher R., Cantell K., Neumann-Haefelin D. Combination therapy of dendritic keratitis with trifluorothymidine and interferon. Lancet. 1978;ii:687. doi: 10.1016/s0140-6736(78)92809-x. [DOI] [PubMed] [Google Scholar]

Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES